Viewing Study NCT01640405


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2026-05-13 @ 5:18 PM
Study NCT ID: NCT01640405
Status: COMPLETED
Last Update Posted: 2019-04-11
First Post: 2012-06-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFOX) + Bevacizumab Versus 5-Fluorouracil/Leucovorin/Oxaliplatin/Irinotecan (FOLFOXIRI) + Bevacizumab as First Line Treatment of Patients With Metastatic Colorectal Cancer Not Previously Treated and With Three or More Circulating Tumoral Cells
Sponsor: Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None colorectal cancer View
None FOLFOX View
None Bevacizumab View
None FOLFOXIRI View
None circulating tumor cell View